A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

SIMPLE SUMMARY: There are limited treatments for patients with HER2-negative breast cancer, especially for patients with metastatic breast cancer. This study aimed to observe the efficacy and safety of low-dose apatinib combined with chemotherapy in real-world clinical diagnosis and treatment of HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Tianyu, Sun, Chunxiao, Liang, Yan, Yang, Fan, Yan, Xueqi, Bao, Shengnan, Zhang, Yucheng, Huang, Xiang, Fu, Ziyi, Li, Wei, Yin, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454649/
https://www.ncbi.nlm.nih.gov/pubmed/36077621
http://dx.doi.org/10.3390/cancers14174084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454649/
https://www.ncbi.nlm.nih.gov/pubmed/36077621
http://dx.doi.org/10.3390/cancers14174084

Ejemplares similares